SIREN : 849525308
PHARMACIE PERCHET is a French company founded 7 years ago, specialized in the sector Activités des sièges sociaux. Based in ROLAMPONT (52260), this company of category PME shows in 2024 a net income positive of 195 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-25
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | N/C | N/C |
| Net income | 195 448 € | 126 391 € | 259 168 € | 250 768 € | 192 887 € | 15 157 € |
| EBITDA | N/C | N/C | N/C | N/C | N/C | N/C |
| Net margin | N/C | N/C | N/C | N/C | N/C | N/C |
In 2024, PHARMACIE PERCHET generates positive net income of 195 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 15 k€ -> 195 k€.
195 448 €
The debt ratio (= Financial debt / Equity x 100) stands at 41%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 64%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
41.171%
64.067%
3.0%
In 2024, the debt ratio of PHARMACIE PERCHET (41.17) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of PHARMACIE PERCHET (64.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
The liquidity ratio (= Current assets / Current liabilities) stands at 614.30. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
614.297
In 2024, the liquidity ratio of PHARMACIE PERCHET (614.30) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Based on 103 transactions of similar company sales in 2024, the value of PHARMACIE PERCHET is estimated at 1 858 303 € (range 638 073€ - 5 003 829€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 103 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare PHARMACIE PERCHET with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sièges sociaux
The revenue of PHARMACIE PERCHET is not publicly disclosed (confidential accounts filed with INPI).
Yes, PHARMACIE PERCHET generated a net profit of 195 k€ in 2024.
The headquarters of PHARMACIE PERCHET is located in ROLAMPONT (52260), in the department Haute-Marne.
The tax return of PHARMACIE PERCHET is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
PHARMACIE PERCHET operates in the sector Activités des sièges sociaux (NAF code 70.10Z). See the 'Sector positioning' section above to compare the company with its competitors.